🔍 Observations
Topline
- Revenue from operations grew 5.1% YoY (₹61,328 Cr → ₹64,468 Cr in FY26), with Q4 FY26 accelerating at 7.6% QoQ flat but 7.6% YoY (₹15,190 Cr → ₹16,351 Cr) — volume-led recovery rather than pricing.
- Beauty & Wellbeing led segment growth at +10.8% YoY (₹13,523 Cr → ₹14,990 Cr); Home Care followed at +3.1% YoY (₹22,958 Cr → ₹23,672 Cr), both outpacing Foods (+4.1%) and Personal Care (+4.3%).
- Ice Cream discontinuation removed ₹1,257 Cr of revenue in FY26 (vs ₹1,793 Cr in FY25) — continuing operations revenue base is now cleaner but headline growth understates organic momentum.
Bottomline
- Continuing operations PAT was nearly flat YoY: ₹10,652 Cr (FY26) vs ₹10,680 Cr (FY25), a marginal -0.3% decline — no earnings growth on a like-for-like basis.
- Reported PAT surged to ₹15,059 Cr vs ₹10,671 Cr (+41.1%) solely due to ₹4,611 Cr gain on Ice Cream demerger — a one-time, non-recurring item.
- Q4 FY26 continuing PAT jumped 20% YoY (₹2,501 Cr → ₹3,002 Cr), aided by a ₹247 Cr exceptional credit vs a ₹134 Cr charge in Q4 FY25 — underlying momentum is moderate, not explosive.
Margins
- FY26 EBIT margin (continuing): Segment EBIT ₹13,721 Cr ÷ Revenue ₹64,468 Cr = 21.3% vs ₹13,453 Cr ÷ ₹61,328 Cr = 21.9% in FY25 — 60 bps compression YoY.
- EBITDA (proxy): PBT before exceptionals ₹14,047 Cr + Finance costs ₹410 Cr + D&A ₹1,333 Cr = ₹15,790 Cr ÷ ₹64,468 Cr = 24.5% vs ₹15,715 Cr ÷ ₹61,328 Cr = 25.6% — 110 bps YoY dilution driven by A&P inflation (+4.5% YoY) and material cost rise.
- Other Income declined sharply: ₹1,017 Cr (FY25) → ₹751 Cr (FY26), down 26% — lower treasury yields and reduced investable surplus weigh on reported PBT.
Growth Trajectory
- Three-year revenue CAGR is modest; FY26’s 5.1% top-line growth mirrors FY25’s underlying pace — no acceleration visible.
- A&P spend rose 4.5% YoY (₹5,989 Cr → ₹6,261 Cr) but as % of revenue fell marginally — brand investment maintained, not expanded.
- Employee costs up 7.5% YoY (₹2,952 Cr → ₹3,175 Cr), growing faster than revenue — operating leverage absent at this growth rate.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Q4 FY26 continuing PAT grew 20% YoY (₹2,501 Cr → ₹3,002 Cr) — sequential earnings recovery suggests H2 momentum is building.
- Beauty & Wellbeing revenue +10.8% YoY — highest-growth segment signals premiumisation is gaining traction and mix improvement is underway.
- Debt-free balance sheet — zero borrowings (current borrowings ₹0) with ₹2,583 Cr cash; financial risk negligible.
- OCF of ₹10,999 Cr remains robust despite elevated tax outflow — underlying cash generation capacity intact.
- Trade payables expanded: ₹11,315 Cr (FY25) → ₹13,325 Cr (FY26) — improved supplier credit terms suggest stronger bargaining power.
- Capital allocation disciplined: Capex ₹1,258 Cr (FY26) vs ₹1,254 Cr (FY25) — no dilutive splurge; asset-light profile maintained.
- Ice Cream demerger completed — discontinuing a structurally challenged, capex-heavy segment improves portfolio quality and long-term ROCE.
🔴 Red Flags
- Continuing PAT flat YoY at -0.3% (₹10,680 Cr → ₹10,652 Cr) — zero earnings growth for shareholders on a clean comparable basis.
- EBITDA margin contracted 110 bps YoY — cost inflation (materials + employees) outpacing revenue growth; operating leverage absent.
- Other Income fell 26% YoY (₹1,017 Cr → ₹751 Cr) — declining treasury income is a structural headwind as cash balances deploy or deplete.
- Cash & equivalents dropped 57%: ₹6,071 Cr → ₹2,583 Cr — partially explained by dividends (₹10,124 Cr paid) and acquisition spend (₹2,661 Cr), but liquidity buffer is visibly thinner.
- Goodwill + Intangibles at ₹49,246 Cr = 61.7% of total assets — heavy intangible loading; impairment risk if acquired brand growth disappoints.
- Taxes paid spiked to ₹4,840 Cr vs ₹2,268 Cr in FY25 — likely deferred tax catch-up; artificially suppresses reported OCF relative to earnings quality.
- Deferred Tax Liability up ₹789 Cr (₹6,685 Cr → ₹7,474 Cr) — growing deferred liability signals timing differences building up, a future cash drag.
📊 Balance Sheet Analysis
- Leverage: Near-zero debt (lease liabilities ₹1,478 Cr total); Debt/Equity effectively nil — balance sheet strength is unquestionable.
- Liquidity: Current ratio = ₹19,021 Cr ÷ ₹15,549 Cr = 1.22x (FY26) vs 1.33x (FY25) — adequate but tightening; lower cash the key driver.
- Asset Quality: Intangibles + Goodwill at ₹49,246 Cr dominate assets — real net worth is substantially lower than reported equity of ₹49,008 Cr on a tangible basis.
- Working Capital: Trade receivables declined (₹3,819 Cr → ₹3,379 Cr) while payables expanded — NWC improvement of ~₹1,177 Cr YoY signals efficient cash conversion.
💰 Cash Flow Analysis
- OCF ₹10,999 Cr (FY26) vs ₹11,886 Cr (FY25): decline driven by ₹2,572 Cr higher tax outflow — pre-tax cash generation actually strengthened.
- FCF (OCF minus Capex): ₹10,999 Cr − ₹1,258 Cr = ₹9,741 Cr — exceptional FCF yield; business generates cash far in excess of reinvestment needs.
- Investing outflow ₹3,684 Cr vs inflow ₹6,473 Cr in FY25 — swing driven by ₹2,661 Cr acquisition spend and ₹824 Cr NCI buyout; no comparable asset sale in FY26.
- Financing outflow ₹10,810 Cr: dividends of ₹10,124 Cr returned ~104% of continuing PAT to shareholders — highly shareholder-friendly but cash-consumptive.
💡 Investment Outlook
HUL is a high-quality, cash-generative franchise with pristine balance sheet mechanics — but FY26 reveals a business in earnings stagnation, not growth.
Continuing PAT flatlined, margins compressed, and top-line growth at 5% barely covers cost inflation.
The Ice Cream demerger is strategically sound and removes a drag, but does not itself create new earnings power.
At current valuations, the investment case rests entirely on a volume recovery and premiumisation cycle; without a demonstrable reacceleration in revenue growth and margin restoration in FY27, the risk/reward is asymmetric for new capital.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial spreadsheets, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.